The correlation between the costs and clinical benefits of national price-negotiated anticancer drugs for specific cancers in China

BACKGROUND: The high costs of novel anticancer drugs have caused concern among healthcare stakeholders. To address the knowledge gap on the proportion of survival benefit with the related economic expenditure, we aimed to assess the correlation between the costs and value of innovative drugs targete...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Yuwen, Liu, Yanyan, Ma, Rui, Zhang, Pei, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629928/
https://www.ncbi.nlm.nih.gov/pubmed/37934965
http://dx.doi.org/10.7189/jogh.13.04140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629928/
https://www.ncbi.nlm.nih.gov/pubmed/37934965
http://dx.doi.org/10.7189/jogh.13.04140

Ejemplares similares